1. Lysophosphatidic acid induces neuronal cell death via activation of asparagine endopeptidase in cerebral ischemia-reperfusion injury.
- Author
-
Wang C, Zhang J, Tang J, Li YY, Gu Y, Yu Y, Xiong J, Zhao X, Zhang Z, Li TT, Chen J, Wan Q, and Zhang Z
- Subjects
- Animals, Brain Ischemia drug therapy, Brain Ischemia pathology, Cysteine Endopeptidases drug effects, Enzyme Activation drug effects, Infarction, Middle Cerebral Artery drug therapy, Infarction, Middle Cerebral Artery pathology, Injections, Intraventricular, Lysophospholipids administration & dosage, Male, PC12 Cells, Rats, Rats, Sprague-Dawley, Reperfusion Injury enzymology, Stroke drug therapy, Stroke pathology, tau Proteins metabolism, Cell Death drug effects, Cysteine Endopeptidases metabolism, Lysophospholipids pharmacology, Neurons drug effects, Reperfusion Injury pathology
- Abstract
Lysophosphatidic acid (LPA), an extracellular signaling molecule, influences diverse biological events, including the pathophysiological process induced after ischemic brain injury. However, the molecular mechanisms mediating the pathological change after ischemic stroke remain elusive. Here we report that asparagine endopeptidase (AEP), a lysosomal cysteine proteinase, is regulated by LPA during stroke. AEP proteolytically cleaves tau and generates tauN368 fragments, triggering neuronal death. Inhibiting the generation of LPA reduces the expression of AEP and tauN368, and alleviates neuronal cell death. Together, this evidence indicates that the LPA-AEP pathway plays a key role in the pathophysiological process induced after ischemic stroke. Inhibition of LPA could be a useful therapeutic for treating neuronal injury after stroke., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF